Unlock Strategic Intelligence with Fundz
Access exclusive insights on funding rounds, strategic shifts with FundzWatch™, Family Offices, and more — faster than your competitors.
Aslan Pharmaceuticals Ltd announced it raised $5 Million in an initial filing from an offering of $5 Million
Aslan Pharmaceuticals Ltd announced it raised $5 Million in an initial filing from an offering of $5 Million
Company Info
Company news
Wed, 17 Jul 2024 07:00:00 GMT
ASLAN Pharmaceuticals Announces it Has Filed for Voluntary - GlobeNewswire
Fri, 19 Jul 2024 07:00:00 GMT
Fierce Pharma Asia—Hengrui's FDA reprimands; Sanofi's India site expansion; Aslan's downfall - Fierce Pharma
Thu, 22 Jun 2023 07:00:00 GMT
ASLAN Pharmaceuticals Enters Into a Strategic Licensing - GlobeNewswire
Thu, 05 Jan 2023 08:00:00 GMT
ASLAN Pharma, Thermo Fisher partner to manufacture atopic dermatitis drug - BioSpectrum Asia
Mon, 30 Sep 2019 07:00:00 GMT
asln-ex991_6.htm - SEC.gov
Fri, 12 Aug 2022 07:00:00 GMT
ASLAN Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update - Yahoo Finance
Wed, 06 Apr 2022 07:00:00 GMT
ASLAN Pharmaceuticals to Present at the Annual Needham Virtual Healthcare Conference 2022 - GlobeNewswire
Tue, 07 May 2024 07:00:00 GMT
ASLAN Pharmaceuticals to Present Additional Data From - GlobeNewswire

Track Every New Funding Round — Before Anyone Else
This is just a small preview. Unlock access to thousands more filtered results — updated in real-time by stage, region, investor & more.
Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.
Related people
CH
KH
Trends
Raised | Growth The data in the raised column shows reported funding for this location/industry over last 90 days. The data in the growth column indicates the % increase or decrease of the last 90 days vs. the previous 90 days. Please note: one or more large fundings, especially for a location/industry that doesn't historically receive much funding, can have a significant impact on the increase or decrease percentage. | |
---|---|---|
$225.7 M | -89.1% | |
biotechnology | $9.1 B | -19.4% |
manufacturing | $5 B | -59.9% |